fbpx

Stephen Baylin

23 results.

May 9, 2018 Fighting cancer is a team effort

By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team Four years ago, we embarked…

December 21, 2017 10 highlights: A look back at 2017

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…

November 30, 2017 Clinical trial investigates possible triple threat for lung cancer

A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other cancer type and…

VAI DEFAULT HEADER
October 12, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…

October 12, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…

May 15, 2017 VARI cancer researcher elected to National Academy of Sciences

GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at

February 3, 2017 In their own words: The most exciting advances in cancer research

In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is…